BioNTech (BNTX) said Tuesday it will invest up to 1 billion British pounds ($1.33 billion) over 10 years to expand its research operations in the UK, supported by a government grant of up to 129 million pounds.
The company said the funding agreement extends BioNTech's ongoing partnership with the UK government and includes plans to open two new research centers and to establish a headquarters in London.
BioNTech said it aims to accelerate clinical trials, expand research areas, and grow its artificial intelligence hub, which is run by its InstaDeep unit.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.